Autolus Therapeutics (AUTL) Earnings
|
Expand Research on AUTL
| Next EPS Date | 10/29/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +3.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -7.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/29/26 |
Q326 | N/A | -$0.17 | N/A | N/A | $38.11M | = | N/A | N/A | ||
| 8/11/26 |
Q226 | -$0.15 | -$0.23 | +$0.08 | $45.69M | $30.08M | = | ![]() | ![]() | Details | |
| 5/14/26 | Q126 | -$0.27 | -$0.25 | -$0.02 | $26.22M | $26.27M | = | ![]() | ![]() | Details | |
| 5/5/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.25 | N/A | N/A | $26.27M | = | N/A | N/A | ||
| 3/27/26 | Q425 | -$0.34 | -$0.25 | -$0.09 | $24.29M | $24.89M | = | ![]() | ![]() | Details |


